No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Hernia Mesh Should Taken Off of the Market Worldwide

Entire countries have banned vaginal support mesh because of the harm the failed medical device has done to women with incontinence but the same medical device continues to be sold for hernia repair

Tuesday, November 19, 2019 - Surgical meshes have been around for decades but now pose such a serious risk of severe medical complications that they should be taken off of the market altogether. In 2016 Johnson & Johnson's Ethicon medical devices unit voluntarily recalled all outstanding Physiomesh Composite Hernia Repair mesh when Germany's Herniamed German Registry and the Danish Hernia Database medical device watch dogs reported an unusually high percentage of hernia mesh failures that required revision surgery. In a truly incomplete and non committal statement, Johnson & Johnson cited "multifactorial" issues without admitting that the product physically malfunctioned. What actually happened was that Physiomesh, made with a composite layer of polypropylene, was structurally degraded by the body's natural immune system causing it to liquefy and calcify into jagged pieces, pull away from the original hernia location, and migrate by gravity down into the lower abdominal cavity where it can painfully lacerate the lower intestines and bowels. Rather than admit the abject failure of the device, lawyers for JNJ wrote in a non-published statement " Ethicon has not been able at this time to issue further instructions to surgeons that might lead to a reduction in the recurrence rate and [has] decided to recall Ethicon Physiomesh composite mesh from the global market. Ethicon will not return Ethicon Physiomesh Composite mesh to the market." Johnson & Johnson's failure to accept responsibility for the mesh device's specific reasons for failure encouraged other companies and Johnson & Johnson themselves to continue to market faulty hernia mesh devices of their own to millions of unsuspecting patients around the world. In England, the hernia mesh crisis has reached a critical mass as the country estimates that one-third of the 500,000 annual hernia mesh patients will experience device malfunctions each year. Other companies failed to follow JNJ's recall lead and have created and supplied the multi-billion dollar market that shows no indications of slowing down any time soon. Ethicon Physiomesh hernia mesh attorneys handling Physiomesh side effects claims offer a no obligation and free consultation before filing a lawsuit claim.

An added complication to hernia mesh failure is the fact that the doctor that implants a patient with hernia repair mesh does not have the training to perform hernia revision surgery, a complicated and major surgical procedure. When hernia meshes calcify and break into pieces it is normally difficult to locate all of it. Hernia mesh can break into dozens of pieces and surgery entails operating in the vicinity of where the patient is experiencing the greatest pain. If 100% of physiomesh is not retrieved on the first attempt a second, third or more major surgeries could be required to retrieve the device, repair the damaged underlying organ and relieve a patient's pain. Quite often pieces of hernia repair mesh will perforate a person's bowel causing it to become encased in scar tissue and cause a dangerous blockage to the body's waste elimination system. Surgery may entail removing a large section of the bowels or intestines to retrieve the device and repair the blockage.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. OnderLaw has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.